Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -920 | -416 | -3,536 | -3,257 | -764 |
| Depreciation Amortization | 27 | 13 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -341 | N/A | 389 | -76 | -147 |
| Other Working Capital | 14 | -13 | 702 | 5 | 9 |
| Other Operating Activity | 641 | 150 | 1,864 | 2,331 | 341 |
| Operating Cash Flow | $-580 | $-266 | $-582 | $-997 | $-561 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | -500 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -500 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-500 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 347 | N/A | 315 | N/A | N/A |
| Debt Issued | 100 | 150 | 417 | 682 | 322 |
| Other Financing Activity | 0 | 0 | 6 | 6 | 16 |
| Financing Cash Flow | $447 | $150 | $738 | $688 | $338 |
| Beginning Cash Position | 151 | 151 | 494 | 494 | 494 |
| End Cash Position | 17 | 35 | 151 | 185 | 272 |
| Net Cash Flow | $-133 | $-116 | $-343 | $-308 | $-222 |
| Free Cash Flow | |||||
| Operating Cash Flow | -580 | -266 | -582 | -997 | -561 |
| Free Cash Flow | -580 | -266 | -582 | -997 | -561 |